Photo by solenfeyissa from unsplash
No antibiotic therapies have been approved for reducing exacerbations and preventing disease progression in non‐cystic fibrosis bronchiectasis (NCFB) patients. Several recent clinical studies have investigated the feasibility of inhaled ciprofloxacin… Click to show full abstract
No antibiotic therapies have been approved for reducing exacerbations and preventing disease progression in non‐cystic fibrosis bronchiectasis (NCFB) patients. Several recent clinical studies have investigated the feasibility of inhaled ciprofloxacin in NCFB, whereas the results were controversial.
Keywords:
non cystic;
cystic fibrosis;
fibrosis bronchiectasis;
inhaled ciprofloxacin
Journal Title: Internal Medicine Journal
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Internal Medicine Journal
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!